Talk:Everolimus

From Wikipedia, the free encyclopedia
Jump to: navigation, search
WikiProject Pharmacology (Rated Start-class)
WikiProject icon This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.
Start-Class article Start  This article has been rated as Start-Class on the project's quality scale.
 ???  This article has not yet received a rating on the project's importance scale.
 

Please, I work with transplats persons I will receive more information about the best therapy, sirolimus or verlimus, and if you have a comparative study betwen these two medications.

Thanks This page is very helpfull. r2ro_99@yahoo.com

Xience[edit]

Should we move the stuff about Xience V into a new Xience V article ? If we do it would be easier to expand it without overwhelming this Everolimus article. Rod57 (talk) 00:46, 7 September 2008 (UTC)

Everolimus Structure[edit]

I believe that there is an error in the structure shown for everolimus. I believe that the methyl group on the ethylene bridge between the lactone and the cyclohexyl ring should be in the R configuration (solid wedge).

F. R. Green III (talk) 15:59, 24 December 2009 (UTC)

Yes, you're right. I'll correct the structure as soon as possible. Fvasconcellos (t·c) 16:10, 24 December 2009 (UTC)

Need more on Kidney cancer[edit]

Probably approved also in Europe for advanced renal cell carcinoma. Rod57 (talk) 20:20, 28 April 2011 (UTC)

Novartis investigating use as anti-aging drug[edit]

". . . Novartis has completed a successful pilot trial examining its cancer drug everolimus as a potential treatment to reverse immunosenescence, or the gradual deterioration of the immune system that occurs with age and is a major cause of disease and death."

http://www.voanews.com/content/reu-drugmakers-push-boundaries-old-age/2510089.html

(Similar content appeared in the Baltimore Sun for 11/13/2014 in an article headlined "Drugmakers look to push bounds of aging." Couldn't find that online 11/13; sometimes articles from the Sun are posted online a couple of days after their appearance in the hard-copy newspaper.)

Jo3sampl (talk) 13:32, 13 November 2014 (UTC)